Thema: US64131A1051
STIM, US64131A1051
business-163870_1920.jpg - Foto: THN
Neuronetics stock trades at EUR 2.04 on Lang & Schwarz
The company has scheduled its next results for November 4, 2026. Investors can use the dated quote as a reference ahead of the report.
ad-hoc-news.de, heute 13:29 Uhr
STIM, US64131A1051
Neuronetics schedules November 4 results for Neuronetics ...
Its next report is set for November 4, 2026. Neuronetics stock costs EUR 2.03 on October 29, 2026 at Lang & Schwarz.
ad-hoc-news.de, 29.10.26 13:32 Uhr
STIM, US64131A1051
Neuronetics schedules November 4 results for Neuronetics ...
Neuronetics stock costs EUR 2.01 on October 27, 2026 beside a USD 160.8 million market value. Results follow November 4.
ad-hoc-news.de, 27.10.26 13:24 Uhr
STIM, US64131A1051
Neuronetics schedules November 4 results for Neuronetics ...
Neuronetics sets November 4, 2026, for third-quarter results. Neuronetics stock posted USD 41.57 million Q2 revenue, above USD 40.17 million consensus.
ad-hoc-news.de, 25.10.26 14:20 Uhr
STIM, US64131A1051
Neuronetics schedules November 4 results for Neuronetics ...
Third-quarter results are due before market open on November 4, 2026. Neuronetics stock costs EUR 1.76 at Lang & Schwarz on October 22, 2026.
ad-hoc-news.de, 22.10.26 13:29 Uhr
STIM, US64131A1051
Neuronetics recalls 179 NeuroStar units and Neuronetics ...
FDA posted a 179-unit recall on October 9, 2026. Neuronetics stock costs EUR 1.71 on October 20, 2026, with Q2 revenue at USD 41.57 million.
ad-hoc-news.de, 20.10.26 13:35 Uhr
STIM, US64131A1051
BTIG maintains USD 6 target for Neuronetics stock at EUR ...
Neuronetics stock costs EUR 1.69 on October 15, 2026. Q2 revenue reached USD 41.57 million versus USD 37.77 million consensus.
ad-hoc-news.de, 15.10.26 12:49 Uhr
STIM, US64131A1051
Neuronetics announced EHR integration and Neuronetics stock ...
Five brokers rate Neuronetics Moderate Buy at USD 4.67. Neuronetics stock costs EUR 1.90 on October 8, 2026 after EUR 1.96.
ad-hoc-news.de, 08.10.26 20:02 Uhr
STIM, US64131A1051
Neuronetics stock gained 1.85 percent after Q2 revenue beat ...
